Related Experiment Video
Updated: Jan 15, 2026

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Alpha defensin immunoassay is more effective for ruling out rather than diagnosing periprosthetic joint infection
Mohammad Kamal Abdelnasser1, Ayat Bakhet2, Amal Hosni2
1Orthopedic Department, Assiut University Hospital, Assiut, 71515, Egypt.
Background:
Accurate and timely diagnosis of periprosthetic joint infection (PJI) is of utmost importance. Although synovial alpha-defensin has shown potential as a biomarker, recent studies have questioned its additional benefit over traditional synovial biomarkers and advised against its routine use. The primary objective is to evaluate the diagnostic accuracy of the alpha-defensin immunoassay in PJI. Secondary objectives include comparing its diagnostic accuracy against traditional biomarkers and assessing our results in the context of existing research to provide a solid perspective on its clinical utility.
Methods:
This is a prospective cohort study. Synovial samples were obtained at the time of revision arthroplasty or from painful arthroplasties. A complete laboratory workup was performed, including CBC, ESR, CRP, WBCs count. Synovial samples were analyzed for leucocytic count, PMN percentage, leucocyte esterase, and alpha-defensin immunoassay. Culture and sensitivity, and histopathology were also done. Patients who met the inclusion criteria were classified into septic and aseptic according to MSIS criteria.
Results:
Ninety joints met our inclusion criteria. Alpha-defensin immunoassay was positive in 36 joints and negative in 54 joints, with 1 false positive and 3 false negatives, resulting in a sensitivity of 92.11% (95% CI, 78.62-98.34%), a specificity of 98.08% (95% CI, 89.74-99.95%), positive predictive value (PPV) of 49.43% (95% CI, 12.28-87.22%), negative predictive value (NPV) of 99.84% (95% CI, 99.52-99.94%) and diagnostic accuracy of 97.96% (95% CI, 92.48-99.78%). The optimal cutoff was 9.2, and the area under the curve (AUC) was 0.945.
Conclusions:
While the alpha defensin immunoassay is not recommended to be used routinely as a screening method for PJI, its high specificity and NPV make it a valuable addition to traditional blood and synovial parameters in the diagnosis of complex hip and knee PJI, particularly for ruling out infection.
Insights
The alpha-defensin immunoassay shows high accuracy for diagnosing periprosthetic joint infection (PJI). While not a routine screening tool, its high specificity and negative predictive value aid in diagnosing complex PJI cases.
Area of Science:
- Orthopedics
- Infectious Diseases
- Clinical Diagnostics
Background:
- Accurate diagnosis of periprosthetic joint infection (PJI) is critical for patient outcomes.
- Synovial alpha-defensin is a potential biomarker, but its added value over traditional markers is debated.
- Evaluating the diagnostic accuracy of alpha-defensin immunoassay in PJI is essential for clinical utility.
Purpose of the Study:
- To evaluate the diagnostic accuracy of the alpha-defensin immunoassay for PJI.
- To compare the diagnostic performance of alpha-defensin against traditional synovial biomarkers.
- To contextualize findings within existing research for a comprehensive clinical perspective.
Main Methods:
- Prospective cohort study design.
- Synovial fluid analysis including leucocytic count, PMN percentage, leucocyte esterase, and alpha-defensin immunoassay.
- Comprehensive laboratory workup (CBC, ESR, CRP, WBCs), culture, sensitivity, histopathology, and classification by MSIS criteria.
Main Results:
- The alpha-defensin immunoassay demonstrated high diagnostic accuracy (97.96%) with sensitivity of 92.11% and specificity of 98.08%.
- The test yielded a high negative predictive value (99.84%), indicating strong reliability in ruling out infection.
- An optimal cutoff of 9.2 and an AUC of 0.945 were determined, supporting its diagnostic performance.
Conclusions:
- Alpha-defensin immunoassay is not recommended for routine PJI screening.
- Its high specificity and negative predictive value make it a valuable adjunct for diagnosing complex hip and knee PJI.
- The test is particularly useful for ruling out periprosthetic joint infection when combined with traditional parameters.

